StockData
Prestige Consumer Healthcare Inc. logo

Prestige Consumer Healthcare Inc. (PBH) stock

PBHNYSEPharmaceutical PreparationsFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3021% below fair value
$49.60−1.02 (-2.02%)

Close on Nov 19, 2026Market cap $2.35BP/E 13.9Yield –

Prestige Consumer Healthcare operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Prestige Consumer Healthcare's operating income for the twelve months ending Jun 30, 2026 was $290.17M, down 13.8% year over year. For fiscal 2026 it was $309.41M, down 8.1% from the year before. Over ten years it grew 1.7% a year on average. The highest annual figure on record is $342.43M in fiscal 2024.

Annual operating income

PeriodPeriod endValueChange
FY2026Mar 31, 2026$309.41M-8.1%
FY2025Mar 31, 2025$336.78M-1.7%
FY2024Mar 31, 2024$342.43M–
FY2023Mar 31, 2023-$22.42M-106.8%
FY2022Mar 31, 2022$329.92M+10.9%
FY2021Mar 31, 2021$297.40M+2.1%
FY2020Mar 31, 2020$291.16M+331.3%
FY2019Mar 31, 2019$67.50M-68.7%
FY2018Mar 31, 2018$215.47M+4.8%
FY2017Mar 31, 2017$205.64M-21.0%
FY2016Mar 31, 2016$260.32M+25.4%
FY2015Mar 31, 2015$207.56M+10.0%
FY2014Mar 31, 2014$188.62M-1.7%
FY2013Mar 31, 2013$191.88M+86.6%
FY2012Mar 31, 2012$102.82M+35.0%
FY2011Mar 31, 2011$76.15M-2.8%
FY2010Mar 31, 2010$78.33M–

Quarterly operating income

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ2 2026Jun 30, 2026$52.52M-26.8%
Q4 FY2026CQ1 2026Mar 31, 2026$75.49M-14.6%
Q3 FY2026CQ4 2025Dec 31, 2025$82.49M-10.3%
Q2 FY2026CQ3 2025Sep 30, 2025$79.67M-5.5%
Q1 FY2026CQ2 2025Jun 30, 2025$71.76M-0.4%
Q4 FY2025CQ1 2025Mar 31, 2025$88.43M+7.6%
Q3 FY2025CQ4 2024Dec 31, 2024$91.96M+5.9%
Q2 FY2025CQ3 2024Sep 30, 2024$84.34M-4.4%
Q1 FY2025CQ2 2024Jun 30, 2024$72.05M-15.4%
Q4 FY2024CQ1 2024Mar 31, 2024$82.15M–
Q3 FY2024CQ4 2023Dec 31, 2023$86.83M-0.4%
Q2 FY2024CQ3 2023Sep 30, 2023$88.25M+4.6%
Q1 FY2024CQ2 2023Jun 30, 2023$85.19M-2.1%
Q4 FY2023CQ1 2023Mar 31, 2023-$281.00M-462.9%
Q3 FY2023CQ4 2022Dec 31, 2022$87.18M+5.6%
Q2 FY2023CQ3 2022Sep 30, 2022$84.38M+7.4%
Q1 FY2023CQ2 2022Jun 30, 2022$87.01M-4.7%
Q4 FY2022CQ1 2022Mar 31, 2022$77.43M+9.1%
Q3 FY2022CQ4 2021Dec 31, 2021$82.59M+12.5%
Q2 FY2022CQ3 2021Sep 30, 2021$78.56M+7.8%
Q1 FY2022CQ2 2021Jun 30, 2021$91.34M+14.0%
Q4 FY2021CQ1 2021Mar 31, 2021$70.94M-4.0%
Q3 FY2021CQ4 2020Dec 31, 2020$73.44M-3.9%
Q2 FY2021CQ3 2020Sep 30, 2020$72.90M+5.1%
Q1 FY2021CQ2 2020Jun 30, 2020$80.12M+12.1%
Q4 FY2020CQ1 2020Mar 31, 2020$73.92M–
Q3 FY2020CQ4 2019Dec 31, 2019$76.40M-1.5%
Q2 FY2020CQ3 2019Sep 30, 2019$69.35M-2.2%
Q1 FY2020CQ2 2019Jun 30, 2019$71.49M-1.4%
Q4 FY2019CQ1 2019Mar 31, 2019-$153.45M–
Q3 FY2019CQ4 2018Dec 31, 2018$77.54M-7.6%
Q2 FY2019CQ3 2018Sep 30, 2018$70.92M-6.3%
Q1 FY2019CQ2 2018Jun 30, 2018$72.49M-8.2%
Q4 FY2018CQ1 2018Mar 31, 2018-$23.10M-143.5%
Q3 FY2018CQ4 2017Dec 31, 2017$83.89M+21.1%
Q2 FY2018CQ3 2017Sep 30, 2017$75.73M+6.6%
Q1 FY2018CQ2 2017Jun 30, 2017$78.96M–
Q4 FY2017CQ1 2017Mar 31, 2017$53.05M–
Q3 FY2017CQ4 2016Dec 31, 2016$69.29M–
Q2 FY2017CQ3 2016Sep 30, 2016$71.06M–

More Prestige Consumer Healthcare figures

See a number that looks wrong?